$ACB Cashflow Statement | Understand Stock

$ACB

$4.02 +$0.12 (3.08%) Live

$ACB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of CAD, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 9 months to Mar 31, 2023	FY2022 12 months to Jun 30, 2022
Operating activities
Net income (loss) from continuing operations
Adjustments for non-cash items:
Unrealized gain on changes in fair value of biological assets
Changes in fair value included in inventory sold
Changes in fair value of inventory and biological assets sold
Depreciation of property, plant and equipment
Amortization of intangible assets
Share-based compensation
Impairment of deposits
Impairment of property, plant and equipment
Impairment of investment in associates
Impairment of loans receivable
Impairment of intangible assets and goodwill
Net interest accrual and accretion
Interest and other income
Deferred tax recovery (expense)
Other gains (losses)
Foreign exchange gain (loss)
Payments
Deferred compensation amortization

Cash provided by (used in) operating activities from continuing operations before changes in non-cash working capital
Changes in non-cash working capital
Net cash provided by (used in) operating activities from continuing operations
Net cash used in operating activities from discontinued operations
Net cash provided by (used in) operating activities
Investing activities
Purchase of short-term investments
Loan receivable
Proceeds from disposal of marketable securities
Disposal of property, plant and equipment
Proceeds from government grant
Purchase of property, plant and equipment and intangible assets
Proceeds from disposal of property, plant and equipment and assets held for sale
Changes in restricted cash
Acquisition of businesses, net of cash acquired
Payment of contingent consideration
Deposits (paid) received
Cash provided by (used in) investing activities from continuing operations
Net cash provided by (used in) investing activities from discontinued operations
Net cash provided by (used in) investing activities

Financing activities
Repayment of long-term loans
Proceeds from loans and borrowings
Repayment of loans and borrowings
Repayment of convertible debenture
Net principal payments of lease liabilities
Restricted cash
Financing fees
Proceeds from issuance of shares
Share issuance costs
Proceeds from stock option exercise
Cash provided by (used in) financing activities from continuing operations
Net cash provided by (used in) financing activities from discontinued operations
Net cash provided by (used in) financing activities

Effect of foreign exchange on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Increase (decrease) in restricted cash
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Comments